Urinary 8-hydroxydeoxyguanosine and urothelial carcinoma risk in low arsenic exposure area

Chi Jung Chung, Chi Jung Huang, Yeong Shiau Pu, Chien-Tien Su, Yung-Kai Huang, Ying Ting Chen, Yu-Mei Hsueh

Research output: Contribution to journalArticle

57 Citations (Scopus)

Abstract

Arsenic is a well-documented human carcinogen and is known to cause oxidative stress in cultured cells and animals. A hospital-based case-control study was conducted to evaluate the relationship among the levels of urinary 8-hydroxydeoxyguanosine (8-OHdG), the arsenic profile, and urothelial carcinoma (UC). Urinary 8-OHdG was measured by using high-sensitivity enzyme-linked immunosorbent assay (ELISA) kits. The urinary species of inorganic arsenic and their metabolites were analyzed by high-performance liquid chromatography (HPLC) and hydride generator-atomic absorption spectrometry (HG-AAS). This study showed that the mean urinary concentration of total arsenics was significantly higher, at 37.67 ± 2.98 μg/g creatinine, for UC patients than for healthy controls of 21.10 ± 0.79 μg/g creatinine (p <0.01). Urinary 8-OHdG levels correlated with urinary total arsenic concentrations (r = 0.19, p <0.01). There were significantly higher 8-OHdG levels, of 7.48 ± 0.97 ng/mg creatinine in UC patients, compared to healthy controls of 5.95 ± 0.21 ng/mg creatinine. Furthermore, female UC patients had higher 8-OHdG levels of 9.22 ± 0.75 than those of males at 5.76 ± 0.25 ng/mg creatinine (p <0.01). Multiple linear regression analyses revealed that high urinary 8-OHdG levels were associated with increased total arsenic concentrations, inorganic arsenite, monomethylarsonic acid (MMA), and dimethylarsenate (DMA) as well as the primary methylation index (PMI) even after adjusting for age, gender, and UC status. The results suggest that oxidative DNA damage was associated with arsenic exposure, even at low urinary level of arsenic.

Original languageEnglish
Pages (from-to)14-21
Number of pages8
JournalToxicology and Applied Pharmacology
Volume226
Issue number1
DOIs
Publication statusPublished - Jan 1 2008

Fingerprint

Arsenic
Carcinoma
Creatinine
Immunosorbents
Atomic absorption spectrometry
Methylation
Oxidative stress
8-oxo-7-hydrodeoxyguanosine
High performance liquid chromatography
Metabolites
Linear regression
Hydrides
Carcinogens
DNA Damage
Case-Control Studies
Cultured Cells
Linear Models
Assays
Spectrum Analysis
Animals

Keywords

  • 8-Hydroxydeoxyguanosine
  • Urinary arsenic profile
  • Urothelial carcinoma

ASJC Scopus subject areas

  • Pharmacology
  • Toxicology

Cite this

Urinary 8-hydroxydeoxyguanosine and urothelial carcinoma risk in low arsenic exposure area. / Chung, Chi Jung; Huang, Chi Jung; Pu, Yeong Shiau; Su, Chien-Tien; Huang, Yung-Kai; Chen, Ying Ting; Hsueh, Yu-Mei.

In: Toxicology and Applied Pharmacology, Vol. 226, No. 1, 01.01.2008, p. 14-21.

Research output: Contribution to journalArticle

Chung, Chi Jung ; Huang, Chi Jung ; Pu, Yeong Shiau ; Su, Chien-Tien ; Huang, Yung-Kai ; Chen, Ying Ting ; Hsueh, Yu-Mei. / Urinary 8-hydroxydeoxyguanosine and urothelial carcinoma risk in low arsenic exposure area. In: Toxicology and Applied Pharmacology. 2008 ; Vol. 226, No. 1. pp. 14-21.
@article{2e6f5c74479c4a4093e9a8321a4c80fa,
title = "Urinary 8-hydroxydeoxyguanosine and urothelial carcinoma risk in low arsenic exposure area",
abstract = "Arsenic is a well-documented human carcinogen and is known to cause oxidative stress in cultured cells and animals. A hospital-based case-control study was conducted to evaluate the relationship among the levels of urinary 8-hydroxydeoxyguanosine (8-OHdG), the arsenic profile, and urothelial carcinoma (UC). Urinary 8-OHdG was measured by using high-sensitivity enzyme-linked immunosorbent assay (ELISA) kits. The urinary species of inorganic arsenic and their metabolites were analyzed by high-performance liquid chromatography (HPLC) and hydride generator-atomic absorption spectrometry (HG-AAS). This study showed that the mean urinary concentration of total arsenics was significantly higher, at 37.67 ± 2.98 μg/g creatinine, for UC patients than for healthy controls of 21.10 ± 0.79 μg/g creatinine (p <0.01). Urinary 8-OHdG levels correlated with urinary total arsenic concentrations (r = 0.19, p <0.01). There were significantly higher 8-OHdG levels, of 7.48 ± 0.97 ng/mg creatinine in UC patients, compared to healthy controls of 5.95 ± 0.21 ng/mg creatinine. Furthermore, female UC patients had higher 8-OHdG levels of 9.22 ± 0.75 than those of males at 5.76 ± 0.25 ng/mg creatinine (p <0.01). Multiple linear regression analyses revealed that high urinary 8-OHdG levels were associated with increased total arsenic concentrations, inorganic arsenite, monomethylarsonic acid (MMA), and dimethylarsenate (DMA) as well as the primary methylation index (PMI) even after adjusting for age, gender, and UC status. The results suggest that oxidative DNA damage was associated with arsenic exposure, even at low urinary level of arsenic.",
keywords = "8-Hydroxydeoxyguanosine, Urinary arsenic profile, Urothelial carcinoma",
author = "Chung, {Chi Jung} and Huang, {Chi Jung} and Pu, {Yeong Shiau} and Chien-Tien Su and Yung-Kai Huang and Chen, {Ying Ting} and Yu-Mei Hsueh",
year = "2008",
month = "1",
day = "1",
doi = "10.1016/j.taap.2007.08.021",
language = "English",
volume = "226",
pages = "14--21",
journal = "Toxicology and Applied Pharmacology",
issn = "0041-008X",
publisher = "Academic Press Inc.",
number = "1",

}

TY - JOUR

T1 - Urinary 8-hydroxydeoxyguanosine and urothelial carcinoma risk in low arsenic exposure area

AU - Chung, Chi Jung

AU - Huang, Chi Jung

AU - Pu, Yeong Shiau

AU - Su, Chien-Tien

AU - Huang, Yung-Kai

AU - Chen, Ying Ting

AU - Hsueh, Yu-Mei

PY - 2008/1/1

Y1 - 2008/1/1

N2 - Arsenic is a well-documented human carcinogen and is known to cause oxidative stress in cultured cells and animals. A hospital-based case-control study was conducted to evaluate the relationship among the levels of urinary 8-hydroxydeoxyguanosine (8-OHdG), the arsenic profile, and urothelial carcinoma (UC). Urinary 8-OHdG was measured by using high-sensitivity enzyme-linked immunosorbent assay (ELISA) kits. The urinary species of inorganic arsenic and their metabolites were analyzed by high-performance liquid chromatography (HPLC) and hydride generator-atomic absorption spectrometry (HG-AAS). This study showed that the mean urinary concentration of total arsenics was significantly higher, at 37.67 ± 2.98 μg/g creatinine, for UC patients than for healthy controls of 21.10 ± 0.79 μg/g creatinine (p <0.01). Urinary 8-OHdG levels correlated with urinary total arsenic concentrations (r = 0.19, p <0.01). There were significantly higher 8-OHdG levels, of 7.48 ± 0.97 ng/mg creatinine in UC patients, compared to healthy controls of 5.95 ± 0.21 ng/mg creatinine. Furthermore, female UC patients had higher 8-OHdG levels of 9.22 ± 0.75 than those of males at 5.76 ± 0.25 ng/mg creatinine (p <0.01). Multiple linear regression analyses revealed that high urinary 8-OHdG levels were associated with increased total arsenic concentrations, inorganic arsenite, monomethylarsonic acid (MMA), and dimethylarsenate (DMA) as well as the primary methylation index (PMI) even after adjusting for age, gender, and UC status. The results suggest that oxidative DNA damage was associated with arsenic exposure, even at low urinary level of arsenic.

AB - Arsenic is a well-documented human carcinogen and is known to cause oxidative stress in cultured cells and animals. A hospital-based case-control study was conducted to evaluate the relationship among the levels of urinary 8-hydroxydeoxyguanosine (8-OHdG), the arsenic profile, and urothelial carcinoma (UC). Urinary 8-OHdG was measured by using high-sensitivity enzyme-linked immunosorbent assay (ELISA) kits. The urinary species of inorganic arsenic and their metabolites were analyzed by high-performance liquid chromatography (HPLC) and hydride generator-atomic absorption spectrometry (HG-AAS). This study showed that the mean urinary concentration of total arsenics was significantly higher, at 37.67 ± 2.98 μg/g creatinine, for UC patients than for healthy controls of 21.10 ± 0.79 μg/g creatinine (p <0.01). Urinary 8-OHdG levels correlated with urinary total arsenic concentrations (r = 0.19, p <0.01). There were significantly higher 8-OHdG levels, of 7.48 ± 0.97 ng/mg creatinine in UC patients, compared to healthy controls of 5.95 ± 0.21 ng/mg creatinine. Furthermore, female UC patients had higher 8-OHdG levels of 9.22 ± 0.75 than those of males at 5.76 ± 0.25 ng/mg creatinine (p <0.01). Multiple linear regression analyses revealed that high urinary 8-OHdG levels were associated with increased total arsenic concentrations, inorganic arsenite, monomethylarsonic acid (MMA), and dimethylarsenate (DMA) as well as the primary methylation index (PMI) even after adjusting for age, gender, and UC status. The results suggest that oxidative DNA damage was associated with arsenic exposure, even at low urinary level of arsenic.

KW - 8-Hydroxydeoxyguanosine

KW - Urinary arsenic profile

KW - Urothelial carcinoma

UR - http://www.scopus.com/inward/record.url?scp=36849095609&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=36849095609&partnerID=8YFLogxK

U2 - 10.1016/j.taap.2007.08.021

DO - 10.1016/j.taap.2007.08.021

M3 - Article

C2 - 17950770

AN - SCOPUS:36849095609

VL - 226

SP - 14

EP - 21

JO - Toxicology and Applied Pharmacology

JF - Toxicology and Applied Pharmacology

SN - 0041-008X

IS - 1

ER -